A Safety and Tolerability Study of INCAGN02390 in Select Advanced Malignancies

Clinical trial NCT03652077 · COMPLETED

Trial details

NCT number: NCT03652077
Sponsor: Incyte Corporation
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Cervical Cancer Gastric Cancer Stomach Cancer Gastroesophageal Junction Cancer Esophageal Cancer Hepatocellular Carcinoma Melanoma Uveal Melanoma Merkel Cell Carcinoma Mesothelioma MSI Non-small Cell Lung Cancer

Start date: 2018-09-24
Primary completion: 2021-08-18
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.